The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tumor Embolization Market Research Report 2025
Synopsis
The global Tumor Embolization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Embolization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Embolization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Embolization in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Embolization include Boston Scientific Corporation, Varian Medical Systems, Inc., Nordion (Sotera Health) and Sirtex Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Embolization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Embolization.
Report Scope
The Tumor Embolization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Embolization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Embolization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Sirtex Medical
Segment by Type
Trans-Arterial Embolization (TAE)
Drug-Eluting Bead Chemoembolization (DEB-TACE)
Radioembolization (RE)
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Embolization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Tumor Embolization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tumor Embolization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Embolization is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Embolization in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Embolization include Boston Scientific Corporation, Varian Medical Systems, Inc., Nordion (Sotera Health) and Sirtex Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Embolization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Embolization.
Report Scope
The Tumor Embolization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Embolization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Embolization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Sirtex Medical
Segment by Type
Trans-Arterial Embolization (TAE)
Drug-Eluting Bead Chemoembolization (DEB-TACE)
Radioembolization (RE)
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Embolization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Embolization Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Trans-Arterial Embolization (TAE)
1.2.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
1.2.4 Radioembolization (RE)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Embolization Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Embolization Market Perspective (2019-2030)
2.2 Tumor Embolization Growth Trends by Region
2.2.1 Global Tumor Embolization Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Embolization Historic Market Size by Region (2019-2024)
2.2.3 Tumor Embolization Forecasted Market Size by Region (2025-2030)
2.3 Tumor Embolization Market Dynamics
2.3.1 Tumor Embolization Industry Trends
2.3.2 Tumor Embolization Market Drivers
2.3.3 Tumor Embolization Market Challenges
2.3.4 Tumor Embolization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Embolization Players by Revenue
3.1.1 Global Top Tumor Embolization Players by Revenue (2019-2024)
3.1.2 Global Tumor Embolization Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Embolization Revenue
3.4 Global Tumor Embolization Market Concentration Ratio
3.4.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2023
3.5 Tumor Embolization Key Players Head office and Area Served
3.6 Key Players Tumor Embolization Product Solution and Service
3.7 Date of Enter into Tumor Embolization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Embolization Breakdown Data by Type
4.1 Global Tumor Embolization Historic Market Size by Type (2019-2024)
4.2 Global Tumor Embolization Forecasted Market Size by Type (2025-2030)
5 Tumor Embolization Breakdown Data by Application
5.1 Global Tumor Embolization Historic Market Size by Application (2019-2024)
5.2 Global Tumor Embolization Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Embolization Market Size (2019-2030)
6.2 North America Tumor Embolization Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Embolization Market Size by Country (2019-2024)
6.4 North America Tumor Embolization Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Embolization Market Size (2019-2030)
7.2 Europe Tumor Embolization Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Embolization Market Size by Country (2019-2024)
7.4 Europe Tumor Embolization Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Embolization Market Size (2019-2030)
8.2 Asia-Pacific Tumor Embolization Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Embolization Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Embolization Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Embolization Market Size (2019-2030)
9.2 Latin America Tumor Embolization Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Embolization Market Size by Country (2019-2024)
9.4 Latin America Tumor Embolization Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Embolization Market Size (2019-2030)
10.2 Middle East & Africa Tumor Embolization Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Embolization Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Embolization Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Tumor Embolization Introduction
11.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2019-2024)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Varian Medical Systems, Inc.
11.2.1 Varian Medical Systems, Inc. Company Detail
11.2.2 Varian Medical Systems, Inc. Business Overview
11.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
11.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2019-2024)
11.2.5 Varian Medical Systems, Inc. Recent Development
11.3 Nordion (Sotera Health)
11.3.1 Nordion (Sotera Health) Company Detail
11.3.2 Nordion (Sotera Health) Business Overview
11.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
11.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2019-2024)
11.3.5 Nordion (Sotera Health) Recent Development
11.4 Sirtex Medical
11.4.1 Sirtex Medical Company Detail
11.4.2 Sirtex Medical Business Overview
11.4.3 Sirtex Medical Tumor Embolization Introduction
11.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2019-2024)
11.4.5 Sirtex Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Tumor Embolization Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Trans-Arterial Embolization (TAE)
Table 3. Key Players of Drug-Eluting Bead Chemoembolization (DEB-TACE)
Table 4. Key Players of Radioembolization (RE)
Table 5. Key Players of Others
Table 6. Global Tumor Embolization Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Tumor Embolization Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Tumor Embolization Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Tumor Embolization Market Share by Region (2019-2024)
Table 10. Global Tumor Embolization Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Tumor Embolization Market Share by Region (2025-2030)
Table 12. Tumor Embolization Market Trends
Table 13. Tumor Embolization Market Drivers
Table 14. Tumor Embolization Market Challenges
Table 15. Tumor Embolization Market Restraints
Table 16. Global Tumor Embolization Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Tumor Embolization Market Share by Players (2019-2024)
Table 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2023)
Table 19. Ranking of Global Top Tumor Embolization Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Tumor Embolization Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tumor Embolization Product Solution and Service
Table 23. Date of Enter into Tumor Embolization Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tumor Embolization Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Tumor Embolization Revenue Market Share by Type (2019-2024)
Table 27. Global Tumor Embolization Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Tumor Embolization Revenue Market Share by Type (2025-2030)
Table 29. Global Tumor Embolization Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Tumor Embolization Revenue Market Share by Application (2019-2024)
Table 31. Global Tumor Embolization Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Tumor Embolization Revenue Market Share by Application (2025-2030)
Table 33. North America Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Tumor Embolization Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Tumor Embolization Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Tumor Embolization Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Tumor Embolization Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Tumor Embolization Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Tumor Embolization Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Tumor Embolization Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Tumor Embolization Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tumor Embolization Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Tumor Embolization Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Tumor Embolization Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Tumor Embolization Market Size by Country (2025-2030) & (US$ Million)
Table 48. Boston Scientific Corporation Company Detail
Table 49. Boston Scientific Corporation Business Overview
Table 50. Boston Scientific Corporation Tumor Embolization Product
Table 51. Boston Scientific Corporation Revenue in Tumor Embolization Business (2019-2024) & (US$ Million)
Table 52. Boston Scientific Corporation Recent Development
Table 53. Varian Medical Systems, Inc. Company Detail
Table 54. Varian Medical Systems, Inc. Business Overview
Table 55. Varian Medical Systems, Inc. Tumor Embolization Product
Table 56. Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2019-2024) & (US$ Million)
Table 57. Varian Medical Systems, Inc. Recent Development
Table 58. Nordion (Sotera Health) Company Detail
Table 59. Nordion (Sotera Health) Business Overview
Table 60. Nordion (Sotera Health) Tumor Embolization Product
Table 61. Nordion (Sotera Health) Revenue in Tumor Embolization Business (2019-2024) & (US$ Million)
Table 62. Nordion (Sotera Health) Recent Development
Table 63. Sirtex Medical Company Detail
Table 64. Sirtex Medical Business Overview
Table 65. Sirtex Medical Tumor Embolization Product
Table 66. Sirtex Medical Revenue in Tumor Embolization Business (2019-2024) & (US$ Million)
Table 67. Sirtex Medical Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Embolization Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tumor Embolization Market Share by Type: 2023 VS 2030
Figure 3. Trans-Arterial Embolization (TAE) Features
Figure 4. Drug-Eluting Bead Chemoembolization (DEB-TACE) Features
Figure 5. Radioembolization (RE) Features
Figure 6. Others Features
Figure 7. Global Tumor Embolization Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Tumor Embolization Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Tumor Embolization Report Years Considered
Figure 14. Global Tumor Embolization Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Tumor Embolization Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Tumor Embolization Market Share by Region: 2023 VS 2030
Figure 17. Global Tumor Embolization Market Share by Players in 2023
Figure 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Embolization as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Tumor Embolization Revenue in 2023
Figure 20. North America Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Tumor Embolization Market Share by Country (2019-2030)
Figure 22. United States Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Tumor Embolization Market Share by Country (2019-2030)
Figure 26. Germany Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Tumor Embolization Market Share by Region (2019-2030)
Figure 34. China Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Tumor Embolization Market Share by Country (2019-2030)
Figure 42. Mexico Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Tumor Embolization Market Share by Country (2019-2030)
Figure 46. Turkey Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Tumor Embolization Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Boston Scientific Corporation Revenue Growth Rate in Tumor Embolization Business (2019-2024)
Figure 49. Varian Medical Systems, Inc. Revenue Growth Rate in Tumor Embolization Business (2019-2024)
Figure 50. Nordion (Sotera Health) Revenue Growth Rate in Tumor Embolization Business (2019-2024)
Figure 51. Sirtex Medical Revenue Growth Rate in Tumor Embolization Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
